Navigation Links
ASEBIO Requests the Alignment of Spain With the European Union's Future Strategy of Bioeconomy
Date:9/29/2010

ASEBIO Requests the Alignment of Spain With the European Union's Future Strategy... -- PAMPLONA, Spain, September 29, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Clinical Trials & Medical Discoveries Click to view news release full screen  

ASEBIO Requests the Alignment of Spain With the European Union's Future Strategy of Bioeconomy

 

PAMPLONA, Spain, September 29, 2010 /PRNewswire/ -- The figures regarding BioSpain 2010 have beaten all previous records, to the extent that it has become the most important event in biotechnology in southern Europe. "Investment in Biotechnology and in R&D+i is crucial in order to prevent our best researchers from moving abroad", warned Jose Maria Fernandez Sousa, president of ASEBIO (Spanish Association.of Biocompanies), during the press conference held to present BioSpain 2010. "Navarre is greatly encouraging these two aspects and proof of this is the enormous interest it has shown in the organisation of this event". In addition, this autonomous government is creating a fund of 500 million euros to invest in this field which has a very promising future.

The most prominent feature of BioSpain 2010 is that of its internationalisation, so necessary for these kinds of companies. In this edition there are a total of 160 companies in 132 stands. Likewise, it is expected that there will be over 2,000 business meetings between approximately 600 companies and organisations, of which 150 are from outside Spain. "Brussels is aware of the importance of biotechnology for Europe's future, which is why it has announced a bioeconomy strategy that has yet to be defined by the European Union", explained Fernandez Sousa. In this context, it is estimated that the biotechnology sector will represent 2.7% of GDP in OECD countries, which is why ASEBIO considers that it would be good for Spain to implement the same strategy.

At the Investor's Forum 30 biotechnology projects have been selected, which will be explained during the congress. The president of ASEBIO recommended that our companies make themselves known internationally in order to attract funding from outside Spain. To achieve this, it is essential that Spanish biotechnology companies participate in the most important international fairs.

Tumour stem cells

The first plenary conference was given by Carlos Cordon-Cardo, from the University of Columbia, who spoke about tumour stem cells. "If we do not understand the origin of cancer, we will not be able to understand its final chapters", he said. According to the lecture, "the most effective strategy is that of identifying these cells in tumours and metastases to then attack them", he explained. In this regard, the identification of these stem cells "could have important clinical applications concerning the prognosis of the disease".

Lucia Cecilia Mercado lcecilia@asebio.com tel: +34-91-210-93-74
'/>"/>

SOURCE Asebio
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug"
2. GeoVax Labs Requests pre-IND Meeting With FDA
3. Stemedica Requests Pre-IND Meeting With FDA
4. The West Michigan Science & Technology Initiative is Named Statewide Reviewer for Life Science Funding Requests Through New Program
5. Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign
6. Biotechnology Value Fund, L.P. Requests Avigen Board to Provide Critical Information to Stockholders
7. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
8. Palatin Announces Strategic Realignment of Operations
9. ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks
10. AMDL, Inc. Announces Strategic Realignment
11. BioSpain 2010 Will Host 2,000 Business Meetings in Which More Than 600 Companies Will Come Together
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Vermillion, Inc. (NASDAQ: VRML ... today announced the formation of the Steering Committee for ... --> Pelvic masses can present physicians ... management. Once pregnancy is ruled out, pelvic masses may ... advanced endometriosis, benign ovarian tumors and gastrointestinal and urinary ...
(Date:2/11/2016)... 11, 2016  Wellcentive today announced it has ... Oregon -based community care organization (CCO) with ... analytics, quality reporting and care management solutions and ... team of quality managers, analysts and care managers ... groups serving FamilyCare members. ...
(Date:2/11/2016)...   BioInformant announces the February 2016 release ... Opportunities, Tools, and Technologies – Market Size, Segments, Trends, ... The first and only market ... BioInformant has more than a decade of historical information ... stem cell type. This powerful 175 page global strategic ...
(Date:2/10/2016)... , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. (NYSE: ... pleased to announce that Mitsui & Co. Ltd., its ... succinic acid plant, is investing an additional CDN$25 million ... increasing its stake from 30% to 40%.  Mitsui will ... bio-succinic acid produced in Sarnia , ...
Breaking Biology Technology:
(Date:2/8/2016)... Czech Republic , February 8, 2016 /PRNewswire/ ... EU-regulated global payment platform which presents innovation for ... Biometrics Authentication feature called VoiceKey. --> ... platform which presents innovation for clients, comfort and ... called VoiceKey. --> Worldcore ...
(Date:2/3/2016)... , February 4, 2016 --> ... SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of 2014. ... to SEK 517.6 M (loss: 30.0). Earnings per share increased ... was SEK 537.4 M (neg: 74.7). , ... Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/3/2016)... 3, 2016 ... the "Emotion Detection and Recognition Market ... Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020" ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition ...
Breaking Biology News(10 mins):